NCT00225485已完成3 期
Phase III Study of Effexor XR for the Treatment of Elderly Patients With Depression
Wyeth is now a wholly owned subsidiary of Pfizer37 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2003年12月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 37
- 主要终点
- Response rate of HAM-D17 (Hamilton Rating Scale for Depression) at the final-on-therapy
研究概览
简要总结
Phase III study evaluating Effexor XR in elderly patients with major depression.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients diagnosed with major depression based on DSM-IV-TR
- •Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of "depressed mood" of HAM-D at baseline
排除标准
- •Patients with schizophrenia or any other psychotic disorder
- •Patients with history or presence of bipolar disorder
结局指标
主要结局
Response rate of HAM-D17 (Hamilton Rating Scale for Depression) at the final-on-therapy
次要结局
- Difference of total score of HAM-D17 between baseline and final-on-therapy
- Remission rate of HAM-D17 at the final-on-therapy
研究者
研究点 (37)
Loading locations...
相似试验
已完成
3 期
Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.DepressionNCT00225524Wyeth is now a wholly owned subsidiary of Pfizer150
已完成
3 期
Study Evaluating Effexor XR for Major Depression.DepressionNCT00225511Wyeth is now a wholly owned subsidiary of Pfizer590
已完成
4 期
Antidepressant Medication Plus Donepezil for Treating Late-life DepressionDepressionDementiaNCT00177671University of Pittsburgh220
已完成
4 期
Treating Alcohol Use In Older Adults With DepressionAlcoholismDepressionNCT00018824US Department of Veterans Affairs74
已完成
3 期
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaNCT01696084Jazz Pharmaceuticals309